Log in Request a Demo

US Pharma & Biotech Neuroscience - PPC Market Share Analysis February 2025

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Neuroscience category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Neuroscience brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Domain Share of clicks
vraylar.com 20.99
cvs.com 12.79
nurtec.com 11.43
rexulti.com 8.94
caplyta.com 6.75
vraylarhcp.com 4.02
fanapt.com 3.27
walmart.com 2.98
nurtec-hcp.com 2.01
migrelief.com 1.9
others 24.92

Copyright © Adthena. All rights reserved.

In the PPC landscape, ‘others’ dominate with 24.92% click share, followed by vraylar.com at 20.99%. CVS and nurtec.com trail with 12.79% and 11.43%, respectively.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Neuroscience brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Date vraylar.com caplyta.com cvs.com rexulti.com nurtec.com vraylarhcp.com fanapt.com theneurologyhub.com nurtec-hcp.com briumvi.com
2025/02/01 20.96% 5.41% 11.64% 2.86% 6.94% 2.29% 0.01% 5.57% 1.92% 5.25%
2025/02/02 36.46% 3.71% 7.65% 2.91% 6.65% 0% 0.01% 3.37% 0.78% 2.81%
2025/02/03 10.91% 5.55% 13.85% 0.02% 10.29% 0.14% 1.18% 4.23% 1.59% 6.71%
2025/02/04 28.34% 12.17% 5% 5.28% 5.09% 0.07% 6.54% 2.04% 2.25% 3.07%
2025/02/05 24.59% 7.61% 12.57% 7.36% 5.32% 0% 7.3% 1.39% 1.17% 1.81%
2025/02/06 19.73% 2.36% 9.71% 2.63% 6.52% 2.16% 5.34% 3.04% 2.36% 3.71%
2025/02/07 26.26% 1.82% 10.7% 7.86% 6.9% 0.04% 4.76% 1.32% 6.1% 2.18%
2025/02/08 16.93% 5.43% 15.41% 10.13% 9% 0.05% 7.15% 2.34% 1.82% 2.26%
2025/02/09 26.15% 4.43% 9.01% 3.48% 7.19% 0% 3.6% 2.15% 3.44% 1.73%
2025/02/10 33.3% 5.08% 8.51% 2.66% 7.26% 2.11% 4.18% 2.74% 2.61% 3.35%
2025/02/11 14.62% 10.81% 21.13% 0% 7.88% 0.14% 3.53% 2.68% 2.49% 4%
2025/02/12 40.69% 5.17% 5.46% 5.58% 8.94% 2.5% 2.94% 2.48% 4.02% 0.49%
2025/02/13 23.86% 3.03% 9.22% 0.01% 12.17% 4.25% 3.73% 3.17% 2.21% 1.31%
2025/02/14 26.51% 6.52% 11.06% 7.67% 7.75% 4.19% 4.44% 3.63% 2.45% 4.88%
2025/02/15 26.79% 4.54% 6.83% 10.69% 10.49% 0.27% 6.95% 2.57% 1.98% 3.59%
2025/02/16 14.99% 9.65% 14.1% 5.6% 7.72% 6.81% 3.13% 4.21% 1.19% 6.54%
2025/02/17 17.46% 6.66% 7.01% 0% 14.12% 14.53% 5.98% 3.38% 4.19% 4.35%
2025/02/18 0% 2.38% 12.34% 7.32% 14.1% 12.27% 6.79% 4.8% 1.86% 3.78%
2025/02/19 20.22% 11.47% 6.98% 0% 11.79% 12.66% 4.87% 3.26% 3.39% 2.1%
2025/02/20 22.05% 4.64% 4.55% 0% 10.92% 17.25% 6.16% 2.47% 4.93% 1.35%
2025/02/21 16.66% 0% 8.12% 3.32% 9.2% 19.85% 3.62% 1.88% 4.54% 7.28%
2025/02/22 6.83% 12.25% 12.92% 0% 11.12% 13.67% 3.8% 2.47% 4% 1.9%
2025/02/23 0% 2.94% 13.84% 0% 12.79% 19.86% 3.91% 2.73% 3.17% 6.73%
2025/02/24 17.37% 5.33% 8.54% 3.47% 11.66% 14.41% 3.27% 3.11% 1.39% 4.99%
2025/02/25 49.4% 6.48% 5.56% 0% 7.94% 4.66% 1.9% 1.27% 1.53% 1.27%
2025/02/26 24.45% 3.07% 5.91% 2.36% 5.58% 3.95% 2.37% 1.78% 2.13% 2.87%
2025/02/27 31.99% 12.12% 2.96% 4.92% 6.2% 0% 1.73% 2.44% 1.18% 2.05%
2025/02/28 34.33% 6.55% 6.47% 6.36% 5.21% 1.88% 1.64% 0.93% 0.91% 0.46%

Copyright © Adthena. All rights reserved.

In February 2025, Vraylar.com dominated PPC spend, peaking at 49.40% on the 25th. Caplyta.com and CVS.com showed consistent activity, while Rexulti.com had sporadic spikes. Nurtec.com maintained steady growth, and Vraylarhcp.com surged mid-month. Fanapt.com and Briumvi.com had minimal fluctuations.

Market Exposure

Competitor Count for US Pharma & Biotech Neuroscience

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Date Competitor Count
2025/02/01 147
2025/02/02 141
2025/02/03 146
2025/02/04 139
2025/02/05 128
2025/02/06 139
2025/02/07 134
2025/02/08 130
2025/02/09 133
2025/02/10 141
2025/02/11 143
2025/02/12 145
2025/02/13 134
2025/02/14 133
2025/02/15 124
2025/02/16 133
2025/02/17 136
2025/02/18 117
2025/02/19 125
2025/02/20 122
2025/02/21 112
2025/02/22 137
2025/02/23 124
2025/02/24 125
2025/02/25 129
2025/02/26 159
2025/02/27 153
2025/02/28 140

Copyright © Adthena. All rights reserved.

February began with 147 advertisers, fluctuating throughout the month. A notable dip to 112 on the 21st was followed by a recovery, peaking at 159 on the 26th. The month concluded with 140 advertisers.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Neuroscience

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Name Market Trend
vraylarhcp.com 6.21%
nurtec.com 2.16%
caplytahcp.com 0.68%
talkiatry.com 0.45%
vitasciences.com 0.42%
qulipta.com -0.46%
walmart.com -0.52%
rexulti.com -2.31%
vraylar.com -2.42%
cvs.com -2.5%

Copyright © Adthena. All rights reserved.

In the past month, vraylarhcp.com surged with a 6.21% click share increase, while cvs.com faced a 2.5% decline.

Campaign Efficiency

US Pharma & Biotech Neuroscience Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date vraylar.com cvs.com rexultihcp.com nurtec.com caplyta.com fanapt.com migrelief.com vraylarhcp.com walmart.com nurtec-hcp.com
2025/02/01 7.02% 18.65% 2.22% 3.78% 2.59% 0.01% 4.46% 2.39% 6.9% 2.16%
2025/02/02 14.41% 14.31% 2.35% 4.14% 2.11% 0.01% 5.64% 0% 5.88% 1.38%
2025/02/03 3.42% 20.63% 2.79% 5.42% 2.51% 1.68% 2.96% 0.07% 6.41% 2.05%
2025/02/04 10.15% 11.01% 4.26% 3.12% 5.57% 9.43% 4.08% 0.05% 8.88% 3.34%
2025/02/05 8.98% 21.03% 3.66% 3.15% 3.31% 10.04% 2.67% 0% 7.92% 1.61%
2025/02/06 7.03% 15.85% 1.91% 4.35% 0.86% 7.3% 3.69% 2.39% 5.77% 3.14%
2025/02/07 8.99% 16.26% 11.07% 4.42% 0.86% 5.8% 1.67% 0.02% 4.69% 7.29%
2025/02/08 5.39% 22.95% 6.67% 4.67% 3.27% 8.84% 2.98% 0.03% 4.06% 2.68%
2025/02/09 8.96% 15.52% 2.44% 3.88% 2.19% 4.9% 5.65% 0% 4.7% 4.53%
2025/02/10 13.4% 15.61% 2.19% 4.66% 2.95% 6.77% 2.32% 2.68% 4.46% 3.25%
2025/02/11 5.83% 28.83% 0.76% 4.67% 5.56% 4.77% 4.31% 0.08% 8.24% 3.14%
2025/02/12 17.46% 9.84% 7.12% 7.48% 3.2% 5.37% 2.83% 3.03% 1.1% 6.05%
2025/02/13 8.89% 15.75% 0% 7.16% 1.63% 5.3% 5.58% 4.54% 5.1% 3.24%
2025/02/14 10.16% 19.81% 2.07% 5.72% 3.72% 6.81% 2.8% 5.16% 3.09% 3.64%
2025/02/15 10.07% 13.09% 8.21% 7.14% 2.46% 10.39% 3.32% 0.18% 3.37% 2.66%
2025/02/16 4.58% 21.75% 3.74% 4.17% 4.2% 4% 5.35% 6.95% 9.69% 1.72%
2025/02/17 5.39% 11.51% 0% 9.76% 2.96% 7.24% 1.16% 13.59% 5.13% 4.67%
2025/02/18 0% 16.18% 6.86% 8.11% 1.03% 7.51% 2.03% 11.31% 2.87% 1.78%
2025/02/19 7.85% 12.41% 0% 8.95% 4.95% 7.28% 2.58% 13.68% 3.37% 4.19%
2025/02/20 7.37% 8.03% 0% 9.45% 1.8% 9.15% 1.68% 19.75% 2.8% 6.29%
2025/02/21 5.73% 12.52% 2.34% 5.52% 0% 5.29% 3.91% 20.19% 9.48% 5.48%
2025/02/22 2.14% 17.78% 0% 7.14% 3.92% 4.77% 4.04% 12.89% 6.4% 4.69%
2025/02/23 0% 21.3% 0% 6.35% 1.28% 4.67% 4.07% 17.62% 5.31% 3.53%
2025/02/24 6.46% 14.53% 2.63% 7.92% 2.37% 4.3% 1.87% 16.25% 5.95% 1.87%
2025/02/25 21.59% 11.8% 0% 6.49% 3.39% 3.22% 3.95% 6.23% 3.23% 2.98%
2025/02/26 8.3% 9.64% 6.09% 3.17% 1.56% 3.45% 2.96% 4.17% 2.09% 2.87%
2025/02/27 13.35% 7.29% 2.4% 4.61% 6.86% 2.68% 1.86% 0% 1.86% 2.15%
2025/02/28 14.57% 12.47% 11.83% 3.94% 3.55% 2.88% 2.75% 2.45% 2.07% 1.84%

Copyright © Adthena. All rights reserved.

In February 2025, Vraylar.com saw fluctuating impressions, peaking at 21.59% on the 25th. CVS.com maintained a strong presence, with a high of 28.83% on the 11th. Rexultihcp.com and Nurtec.com showed moderate activity, while Fanapt.com and Migrelief.com had lower shares. Vraylarhcp.com surged mid-month, and Walmart.com had a steady decline. The month concluded with varied performances across domains.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Neuroscience

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
  1. 1
    Suffering From Schizophrenia? - See Treatment Prescription treatment website

    Learn about an FDA-approved treatment that may help adult schizophrenia symptoms. Talk to your healthcare provider to see if this treatment option is right for you. Treatment Info. FAQs. Patient Stories. Safety Information.

  2. 2
    Nurtec® ODT (rimegepant) - See How It Works https://www.nurtec.com

    View efficacy data and hear from real patients taking this treatment. See study results for Nurtec ODT to learn more about treatment. Access resources.

  3. 3
    REXULTI® (brexpiprazole) - Official Patient Website https://www.rexulti.com/

    View REXULTI® Safety & Prescribing Info, & Boxed Warning. Visit The Official Patient Site. The...

  4. 4
    REXULTI® (brexpiprazole) - Official Physician Website https://www.rexultihcp.com/

    View REXULTI® Safety & Prescribing Info, & Boxed Warning. Visit The Official HCP Website. See If...

  5. 5
    VRAYLAR® (cariprazine) - Hear Real Patient Stories https://www.vraylar.com/

    See VRAYLAR® (cariprazine) Full Prescribing Information, Including Boxed Warnings. Start the...

Copyright © Adthena. All rights reserved.

In the competitive landscape of pharmaceuticals, top-performing Google PPC ads reveal a focus on patient empowerment and safety. Fanapt.com targets schizophrenia sufferers with FDA-approved treatment insights. Nurtec.com highlights efficacy and patient experiences. Rexulti.com and Vraylar.com emphasize safety, prescribing information, and real patient stories, fostering trust and informed decision-making.

Frequently Asked Questions

Customer Success Stories

the7stars Case study: PPC campaign Optimization

the7stars case study: Achieving Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study
Sage Case study: Brand protection strategy

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.